Sequentify

Novel Library-Prep Solutions for Next-Generation Sequencing

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2021 by Tom Fleischer, Tamir Biezuner, and Ophir Herbst, Sequentify operates with 1–10 employees. The company has raised $11.1M across three funding rounds, with OurCrowd as an investor. In January 2024, Sequentify was awarded a grant by the Israel Innovation Authority for an infectious disease sequencing panel.

Business overview

Sequentify develops genomic sample processing products and technologies designed for next-generation sequencing hardware. The company's core offering, InfiniSeq, aims to make targeted DNA sequencing as common, fast, and affordable as a blood test, thereby enabling significant growth in personalized medicine. Sequentify serves the health tech and life sciences sectors, focusing on areas like genomics, diagnostics, medical technologies, cancer, biotechnology, and oncology.

Strategic signal

In June 2025, Sequentify partnered with Bio Molecular Systems to release the InfiniSeq Protocol for the Myra liquid handling system, automating NGS library preparation. This collaboration signals a strategic move towards enhancing the efficiency and scalability of genomic sequencing, which is crucial for broader adoption in research and clinical settings and demonstrates the company's commitment to streamlining laboratory workflows.

Company Intelligence Q&A

What is Sequentify's primary product?
Sequentify's primary product is InfiniSeq, a suite of library preparation solutions designed for next-generation sequencing.
When was Sequentify founded and by whom?
Sequentify was founded in January 2021 by Tom Fleischer, Tamir Biezuner, and Ophir Herbst.
Which organization awarded Sequentify a grant in January 2024?
In January 2024, Sequentify was awarded a grant by the Israel Innovation Authority for an infectious disease sequencing panel.
What was the strategic partnership announced in June 2025?
In June 2025, Sequentify partnered with Bio Molecular Systems to release the InfiniSeq Protocol for the Myra liquid handling system, automating NGS library preparation.
What is Sequentify's total funding?
Sequentify has raised a total of $11.1M across three funding rounds, with OurCrowd as an investor.

External links